These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18934526)

  • 1. The effect of caronamide and heparin on the coagulation time of human blood.
    SIRAK HD; McCLEERY RS; ARTZ CP
    Health Cent J; 1948 Mar; 1(2):112. PubMed ID: 18934526
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of caronamide with heparin on the coagulation of human blood; a preliminary report.
    SIRAK HD; McCLEERY RS; ARTZ CP
    Surgery; 1948 Nov; 24(5):811-8. PubMed ID: 18893381
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coagulation time in subcutaneous heparin treatment].
    von AHN
    Sven Lakartidn; 1959 Dec; 56():3409-16. PubMed ID: 13792141
    [No Abstract]   [Full Text] [Related]  

  • 4. Significance of clotting tests augmented by heparin.
    WEINER M; JIMINEZ M
    Am J Clin Pathol; 1956 Mar; 26(3):243-6. PubMed ID: 13302169
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of temperature upon the heparin and citrate clotting times.
    LOSNER S; VOLK BW
    Am J Med Sci; 1953 Jul; 226(1):60-4. PubMed ID: 13065283
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the effect of heparin on factor V and factor VII complex in the human circulation].
    HENGSTMANN H; BECKER M
    Dtsch Arch Klin Med; 1962; 207():637-51. PubMed ID: 13906442
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma prothrombin-proconvertin content following therapeutic doses of heparin].
    MUNCK O
    Ugeskr Laeger; 1956 Jan; 118(2):38-9. PubMed ID: 13312131
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative inability of heparin to prolong clotting time of oxalated and resin-treated blood and plasma.
    SALOMON L; STEFANINI M
    Proc Soc Exp Biol Med; 1953 Nov; 84(2):476-8. PubMed ID: 13121078
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of heparin on three whole blood activated clotting tests and thrombin time.
    Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR
    ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin and Bivalirudin on the kinetics of clot formation: Viscoelastic coagulation testing.
    Hasija S; Kapoor PM
    Ann Card Anaesth; 2017; 20(1):122. PubMed ID: 28074815
    [No Abstract]   [Full Text] [Related]  

  • 11. [Research on the mechanism of action of pcmaccelerin (factor V, labile factor). III. Inhibition of proaccelerin by heparin].
    GOBBI F; ASCARI E; BARBIERI U
    Prog Med (Napoli); 1961 Nov; 17():767-76. PubMed ID: 13899354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of exogenous heparin on heparinemia and coagulation in coronary arteriosclerosis].
    Szigeti I; Kótay-Lákatos E; Vertán MZ; Kiss R
    Med Interna (Bucur); 1967 May; 19(5):549-52. PubMed ID: 6077944
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose heparin in gynecologic surgery: effect on blood coagulation tests.
    Levesque G; Samama M; Kher A; Barbier P; Horellou MH; Conard J
    Haemostasis; 1981; 10(2):97-103. PubMed ID: 7461507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model.
    Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F
    Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apparatus for automatic determination of blood tolerance to heparin].
    Lakin KM; Efimov VS; Barsukov II
    Farmakol Toksikol; 1970; 33(3):371-6. PubMed ID: 5453037
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of the anticoagulant effect of heparin.
    Estes JW
    JAMA; 1970 Jun; 212(9):1492-5. PubMed ID: 5467541
    [No Abstract]   [Full Text] [Related]  

  • 17. Monitoring the effect of heparin bolus during percutaneous coronary angioplasty (PTCA): assessment of three bedside coagulation monitors.
    Hézard N; Metz D; Potron G; Nazeyrollas P; Maes D; Droulle C; Mulpas MC; Elaerts J; Nguyen P
    Thromb Haemost; 1998 Nov; 80(5):865-6. PubMed ID: 9843190
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of heparin in infants with consumption coagulation disease caused by septicemia].
    de Aquino-Jaso ME; Olvera-Hidalgo C; Ramírez JI
    Bol Med Hosp Infant Mex; 1974; 31(1):73-84. PubMed ID: 4433389
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of heparinized intraarterial lines to obtain coagulation samples.
    Harper J
    Focus Crit Care; 1988 Oct; 15(5):51-5. PubMed ID: 3197847
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.